Clinically, there is a marked reduction in the expression levels of the enzyme retinaldehyde dehydrogenase 1 (RALDH1), which is necessary for the conversion of retinaldehyde to RA, in the mDA neurons of post-mortem brain PD patients (Galter et al., 2003). This evidence concerns the gene ALDH1A1 and Parkinson disease.